Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Current Opinion in Molecular Therapeutics|March 16, 2001
Chemotherapy: friend or foe to cancer vaccines?L A Emens, J P Machiels, R T Reilly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2007
Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancerF Ruthotto, F Papendorf, G Wegener, et al.
The Journal of Experimental Medicine|November 1, 1995
A reassessment of the role of B7-1 expression in tumor rejectionT C Wu, A Y Huang, E M Jaffee, et al.
AIDS (London, England)|October 1, 1995
Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replicationJ B Angel, B M Saget, S P Walsh, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|November 1, 1992
Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccinesP T Golumbek, F M Hamzeh, E M Jaffee, et al.
British Journal of Cancer|May 5, 2005
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patientsT F Greten, F Papendorf, J S Bleck, et al.
Cancer Research|December 15, 1993
Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine designP T Golumbek, R Azhari, E M Jaffee, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Enhanced immune priming with spatial distribution of paracrine cytokine vaccinesE M Jaffee, M C Thomas, A Y Huang, et al.
Pageof 7